Jun 2, 2021
NCT04735575: Phase 1/2: Study of EMB-06 in Participants With Relapsed or Refractory Myeloma
Anti-BCMA/Anti-CD3 Bispecific Antibody EMB-06 NCT04735575: Phase 1/2: Study of EMB-06 in Participants With Relapsed or Refractory Myeloma...
203
top of page
Posts Archive
bottom of page